AMDS Hybrid Prosthesis
Tracked across 1 events · 6 articles · First seen Jun 29, 2026 · Last active Jun 29, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: The AMDS Hybrid Prosthesis received PMA approval, allowing for broader adoption and use in treating acute DeBakey Type I aortic dissections. It has shown significant reductions in mortality and major adverse events.
Jun 29, 2026 · 6 articles
100
United States — Food and Drug Administration approved application AMDS Hybrid ProsthesisArtivion AMDS Prosthesis...
ERGEN INTELLIGENCE
Track AMDS Hybrid Prosthesis live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard